These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10083618)

  • 1. The role of Fas/FasL apoptotic pathway in the development of chronic rejection.
    Subbotin V; Sun H; Aitouche A; Salam A; Valdivia LA; Fung JJ; Starzl TE; Rao AS
    Transplant Proc; 1999; 31(1-2):1397-8. PubMed ID: 10083618
    [No Abstract]   [Full Text] [Related]  

  • 2. GvHD after small bowel transplantation: the role of caspases, FAS-L, and galectin-1.
    Fändrich F; Zepernick-Kalinski C; Lin X
    Transplant Proc; 1998 Sep; 30(6):2594-5. PubMed ID: 9745506
    [No Abstract]   [Full Text] [Related]  

  • 3. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD95L confers immune priviledge to liver grafts which are spontaneously accepted.
    Fändrich F; Lin X; Zhu X; Klöppel G; Parwaresch R; Kremer B
    Transplant Proc; 1998 Jun; 30(4):1057-8. PubMed ID: 9636427
    [No Abstract]   [Full Text] [Related]  

  • 5. Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection.
    Subbotin V; Sun H; Aitouche A; Salam A; Valdivia LA; Fung JJ; Starzl TE; Rao AS
    Transplantation; 1999 May; 67(10):1295-300. PubMed ID: 10360580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medial cell apoptosis precedes the development of intimal hyperplasia after transient allogeneic exposure in a rat aortic allograft model of chronic rejection.
    Hare GM; Lee TD; Jordan JL; Hirsch GM
    Transplant Proc; 1999; 31(1-2):1384-5. PubMed ID: 10083612
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection.
    Subbotin V; Sun H; Chen C; Aitouche A; Valdivia L; Fung JJ; Starzl TE; Rao AS
    Transplant Proc; 1998 Jun; 30(4):941-2. PubMed ID: 9636378
    [No Abstract]   [Full Text] [Related]  

  • 8. Contribution of Fas ligand to cardiac allograft rejection.
    Seino K; Kayagaki N; Bashuda H; Okumura K; Yagita H
    Int Immunol; 1996 Sep; 8(9):1347-54. PubMed ID: 8921411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis of crypt cells and lymphocytes in gut-associated lymphoid tissues during small intestinal graft rejection in rats.
    Park YJ; Fujisaki S; Kimizuka K; Shugito K; Tomita R; Fukuzawa M; Matsumoto K
    Transplant Proc; 2004 Mar; 36(2):353-5. PubMed ID: 15050157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular biology of chronic rejection.
    Häyry P; Alatalo S; Myllärniemi M; Räisänen-Sokolowski A; Lemström K
    Transplant Proc; 1995 Feb; 27(1):71-4. PubMed ID: 7879153
    [No Abstract]   [Full Text] [Related]  

  • 11. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
    Taylor MA; Ward B; Schatzle JD; Bennett M
    Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis is involved in acute cardiac allograft rejection in rats.
    Kageyama Y; Li XK; Suzuki S; Suzuki H; Suzuki K; Kazui T; Harada Y
    Ann Thorac Surg; 1998 Jun; 65(6):1604-9. PubMed ID: 9647066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Fas-Fas ligand interaction in donor-specific transfusion-induced tolerance to H-Y antigen.
    Minagawa R; Okano S; Tomita Y; Shimizu I; Iwai T; Kishihara K; Nomoto K; Sugimachi K; Nomoto K
    Transplant Proc; 2001; 33(1-2):283. PubMed ID: 11266820
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of CD14 and lipopolysaccharide binding protein mRNA expression as markers for acute rejection in rat small bowel transplantation.
    Cicalese L; Freeswick PD; Watkins SC; Kelly E; Zeidan M; Rao AS; Stanko RT
    Transplant Proc; 1996 Oct; 28(5):2470. PubMed ID: 8907907
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.
    Silva DG; Petrovsky N; Socha L; Slattery R; Gatenby P; Charlton B
    J Immunol; 2003 May; 170(10):4996-5002. PubMed ID: 12734343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of alloantigen-independent factors in transplant arteriosclerosis.
    Kouwenhoven EA; Marquet RL; Bonthuis F; IJzermans JN; de Bruin RW
    Transplant Proc; 1997 May; 29(3):1721-2. PubMed ID: 9142246
    [No Abstract]   [Full Text] [Related]  

  • 17. An orthotopic aortic graft mouse model to study the immunopathology of chronic vascular rejection.
    Thomsen M; Dambrin C; Uro-Coste E; Subra C; Britton S; Joffre O; Calise D; Arbiol C; Thiers JC; Bayard F; Blaes N; Benoist H
    Transplant Proc; 2002 Nov; 34(7):2833-5. PubMed ID: 12431626
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of Fas ligand-induced apoptosis by TNF.
    Elzey BD; Griffith TS; Herndon JM; Barreiro R; Tschopp J; Ferguson TA
    J Immunol; 2001 Sep; 167(6):3049-56. PubMed ID: 11544288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased presence of mast cells and interleukin-4 during chronic rejection of rat intestinal allografts.
    Walgenbach KJ; Heeckt PF; Stanson JD; Whiteside TL; Bauer AJ
    Transplant Proc; 1996 Oct; 28(5):2454. PubMed ID: 8907896
    [No Abstract]   [Full Text] [Related]  

  • 20. An investigation into the effects of cyclosporine and FK 506 on the progress of chronic rejection in the rat aortic model.
    Cole OJ; Stubington SR; Rigg KM; Shehata M
    Transplant Proc; 1998 Jun; 30(4):991. PubMed ID: 9636400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.